Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

Nicole Fawcett photo
Health Lab
Detecting When the Most Common Skin Cancer Turns Dangerous
A University of Michigan study finds a biomarker associated with basal cell carcinoma may help signal which skin tumors will be more aggressive.
Health Lab
Medicine with the Stars? Celebrities Sway Medical Decisions
A University of Michigan study examines how media coverage of celebrity health has influenced breast cancer treatment decisions including double mastectomy.
Health Lab
When It’s Not Exactly Cancer: Renaming Early Stage Thyroid Tumors
Researchers at the University of Michigan suggest categorizing non-life-threatening thyroid tumors separately from more aggressive thyroid cancers.
Health Lab
How Immune Cells Could Guide Cancer Treatment Decisions
New medical research from the University of Michigan explores how a patient’s own immune system might help determine effective treatment options for cancer.
Health Lab
For Breast Cancer, When Does Worry Outweigh Risk?
A University of Michigan Comprehensive Cancer Center study found 25 percent of low-risk patients substantially overestimated their risk of distant recurrence.
Health Lab
How a Healthy Gut Could Lead to Better Bone Marrow Transplants
A study at the University of Michigan suggests we can prevent graft-versus-host disease by bolstering the amount of the microbiome-derived metabolite butyrate.
Health Lab
How Paid Sick Leave Lowers Cancer’s Financial Burden
A study at the University of Michigan Medical School finds that cancer patients who have paid sick leave are more likely to keep their jobs.
Health Lab
A New Approach to Preserving Fertility During Cancer Treatment
University of Michigan researchers have developed a new healthcare innovation that could help young women with cancer preserve fertility after chemotherapy.